Literature DB >> 778995

Viral interference and interferon.

F Dianzani.   

Abstract

Viral interference is a phenomenon for which a cell infected by a virus becomes resistant toward a second outcoming infection by a superinfectant virus. Even though other mechanisms are known, it can be assumed that most cases of viral interference occurring in natural conditions are mediated by interferon, a low molecular weight protein produced by the infected cell in response to a stimulus provided by viral nucleic acid(s). The interferon produced by a cell can migrate to other cells not yet involved by the spreading infection, transmitting to them the antiviral-resistant state. Available evidence indicates that interferon acts by inducing the production of a second cellular protein, called antiviral protein, which is directly responsible for the antiviral state through some alterations of the cellular, virus-directed, proteosynthetic system. In addition to the antiviral activity, the interferon system can affect the growth of several nonviral organisms and that of tumour cells; rather controversial effects have been shown also on the immune responses; the mechanisms underlying these effects are still nuclear. However a relationship to the specific immune system is suggested also by the finding that interferon can be liberated by sensitized T-lymphocytes following antigenic stimulus. Activation of the interferon system can be operated in vitro and in vivo also by several non-viral substances of various nature, such as nucleic acids, polysaccharides, aromatic amines, etc. This fact, considering that interferon has been shown to play a critical role on the mechanisms of recovery from viral infections, may open new perspectives for their possible prophylactic and/or therapeutic use in viral diseases. This problem can be approached also by administering exogenous interferon. Encouraging preliminary results have so far been obtained either with interferon or its inducers. However, several problems of various nature have to be resolved before considering the actual use of interferon system as a wide range antiviral drug in natural viral diseases of man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 778995     DOI: 10.1007/bf02908284

Source DB:  PubMed          Journal:  Ric Clin Lab        ISSN: 0390-5748


  17 in total

Review 1.  MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors:  Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

3.  Experimental co-infections of domestic ducks with a virulent Newcastle disease virus and low or highly pathogenic avian influenza viruses.

Authors:  Mary J Pantin-Jackwood; Mar Costa-Hurtado; Patti J Miller; Claudio L Afonso; Erica Spackman; Darrell R Kapczynski; Eric Shepherd; Diane Smith; David E Swayne
Journal:  Vet Microbiol       Date:  2015-02-16       Impact factor: 3.293

Review 4.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  Virus interference between H7N2 low pathogenic avian influenza virus and lentogenic Newcastle disease virus in experimental co-infections in chickens and turkeys.

Authors:  Mar Costa-Hurtado; Claudio L Afonso; Patti J Miller; Erica Spackman; Darrell R Kapczynski; David E Swayne; Eric Shepherd; Diane Smith; Aniko Zsak; Mary Pantin-Jackwood
Journal:  Vet Res       Date:  2014-01-06       Impact factor: 3.683

Review 6.  Avian Respiratory Coinfection and Impact on Avian Influenza Pathogenicity in Domestic Poultry: Field and Experimental Findings.

Authors:  Ahmed Samy; Mahmoud M Naguib
Journal:  Vet Sci       Date:  2018-02-24

Review 7.  Coinfections and their molecular consequences in the porcine respiratory tract.

Authors:  Georges Saade; Céline Deblanc; Juliette Bougon; Corinne Marois-Créhan; Christelle Fablet; Gaël Auray; Catherine Belloc; Mily Leblanc-Maridor; Carl A Gagnon; Jianzhong Zhu; Marcelo Gottschalk; Artur Summerfield; Gaëlle Simon; Nicolas Bertho; François Meurens
Journal:  Vet Res       Date:  2020-06-16       Impact factor: 3.683

8.  Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia.

Authors:  Manel Essaidi-Laziosi; Johan Geiser; Song Huang; Samuel Constant; Laurent Kaiser; Caroline Tapparel
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

Review 9.  Interferon for the treatment of genital warts: a systematic review.

Authors:  Jin Yang; Yu-Guo Pu; Zhong-Ming Zeng; Zhi-Jian Yu; Na Huang; Qi-Wen Deng
Journal:  BMC Infect Dis       Date:  2009-09-21       Impact factor: 3.090

10.  Enhanced pathogenicity of low-pathogenic H9N2 avian influenza virus after vaccination with infectious bronchitis live attenuated vaccine.

Authors:  Zainab Mohamed Ismail; Ayman Hanea El-Deeb; Mounir Mohamed El-Safty; Hussein Aly Hussein
Journal:  Vet World       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.